USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
NANOPARTICLE BIOCHEM, INC.
Address:
2814 WILD PLUM CT.
COLUMBIA, MO 65201-
Phone:
N/A
URL:
N/A
EIN:
412164429
DUNS:
787875579
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $240,880.00 2
SBIR Phase II $1,002,558.00 1

Award List:

SBIR TOPIC 252 -COMMERCIALLY VIABLE SYNTHESIS OF MULTIFUNCTIONAL CANCER RECEPTOR

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$135,973.00
Agency:
HHS
Principal Investigator:
Anandhi Upendran
Abstract:
In this Phase I SBIR contract, Nanoparticle Biochem Inc (NBI) proposes to develop commercially viable synthetic methodology for the production of multifunctional gold Nanoparticle-bombesin conjugate. Gold Nanoparticle-bombesin (AuNP-BBN) conjugate is a pot ential clinical imaging and therapeutic… More

IN VIVO COMPATIBLE AND READILY INJECTABLE GOLD NANO CONSTRUCTS FOR TUMOR THERAPY

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$104,907.00
Agency:
HHS
Principal Investigator:
Abstract:
The objective of this proposal is to develop nanoparticulate therapeutic products from the readily injectable Gold-198 (Au-198) nanoconstructs invented at the University of Missouri and licensed to Nanoparticle Biochem, Inc. The Phase I effort embodies thr ee aims: (1) Optimization of synthetic… More

Not Available

Award Year / Program / Phase:
2010 / SBIR / Phase II
Award Amount:
$1,002,558.00
Agency:
HHS
Principal Investigator:
Wynn Volkert
Abstract:
As part of the SBIR Phase I effort, Nanoparticle Biochem Inc has successfully completed detailed therapeutic efficacy studies of NBI-29 (GA-198AuNP; GA = gum arabic) in prostate tumor bearing mice and toxicity studies of the non radioactive surrogate of NBI 29 in pigs. In order to clinically… More